Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof

C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof

US Patent 9938268 · Granted Apr 10, 2018

Estimated economic value: $62,414,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of biological enzyme for preparing orlistat intermediate, and preparation me2025
Substituted piperidino compounds and related methods of treatment2025
Treatment of respiratory tract diseases and infections with ascorbic acid compos2025
Potent ASGPR-binding compounds for the degradation of immunoglobulins and other 2025
ASGPR-binding compounds for the degradation of extracellular proteins2025
ASGPR-binding compounds for the degradation of extracellular proteins2025
ASGPR-binding compounds for the degradation of extracellular proteins2024
Potent ASGPR-binding compounds for the degradation of immunoglobulins and other 2024
GCN2 inhibitors and uses thereof2024
ASGPR-binding compounds for the degradation of extracellular proteins2024
Substituted macrocyclic compounds and related methods of treatment2024
Substituted macrocyclic compounds and related methods of treatment2024